IceCure Medical Ltd. (ICCM) vs Telesis Bio Inc. (TBIO)

IceCure Medical Ltd. and Telesis Bio Inc. are both Medical Devices companies. IceCure Medical Ltd. is the larger, with a market value of $6.5M against $5.3M — 1.2× the size. Telesis Bio Inc. grew revenue faster over the last twelve months: −38.1% against −41.1%. Telesis Bio Inc. has the higher net margin (−287.9% vs −570.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Telesis Bio Inc. leads on 10 and IceCure Medical Ltd. on 5.

Valuation

Metric ICCM TBIO Medical Devices median
P/E n/m n/m 22.18
P/S 1.57 n/m 2.70
P/B 0.36 n/m 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA 0.50 n/m 11.78
EV/Sales (2.83) 0.10 2.38
Earnings yield (352.16%) 0.00% (8.22%)
Free cash flow yield (486.68%) 0.00% (7.80%)

Profitability

Metric ICCM TBIO Medical Devices median
Gross margin 28.13% 45.62% 56.01%
Operating margin (574.61%) (265.73%) (15.03%)
Net margin (570.14%) (287.90%) (20.40%)
Free cash flow margin 0.00% (143.25%) (7.24%)
Return on equity 0.00% 1,013.88% (15.32%)
Return on assets 0.00% (73.87%) (19.72%)
Return on invested capital 0.00% 0.00% (10.33%)

Growth

Metric ICCM TBIO Medical Devices median
Revenue growth (TTM) (41.07%) (38.09%) 8.80%
EPS growth (last fiscal year) 20.00% 0.61% —
Revenue growth, 5-year CAGR (2.67%) 41.76% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ICCM TBIO Medical Devices median
Debt to equity 0.00 (0.23) 0.07
Current ratio 2.88 1.23 2.50
Net debt to EBITDA 0.60 0.46 0.49

Dividend

Metric ICCM TBIO Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric ICCM TBIO Medical Devices median
Market cap 6.48m 5.31m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack